These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 24578935)
61. Functional polymorphisms in the IL6 gene promoter and the risk of urinary bladder cancer in India. Gautam KA; Muktanand T; Sankhwar SN; Goel A; Sankhwar PL; Rajender S Cytokine; 2016 Jan; 77():152-6. PubMed ID: 26605964 [TBL] [Abstract][Full Text] [Related]
62. Screening of N-ras gene mutations in urothelial cell carcinomas of the urinary bladder in the Kashmiri population. Pandith AA; Shah ZA; Khan NP; Bhat AY; Wani SM; Siddiqi MA Asian Pac J Cancer Prev; 2009; 10(6):1063-6. PubMed ID: 20192584 [TBL] [Abstract][Full Text] [Related]
63. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India. Srivastava DS; Mandhani A; Mittal RD Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441 [TBL] [Abstract][Full Text] [Related]
64. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation. Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438 [TBL] [Abstract][Full Text] [Related]
65. Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer. Bai S; Feng Q; Pan XY; Zou H; Chen HB; Wang P; Zhou XL; Hong YL; Song SL; Yang JL Int J Mol Med; 2017 Apr; 39(4):861-868. PubMed ID: 28259994 [TBL] [Abstract][Full Text] [Related]
66. Association of interleukin-1Ra gene polymorphism in patients with bladder cancer: case control study from North India. Bid HK; Manchanda PK; Mittal RD Urology; 2006 May; 67(5):1099-104. PubMed ID: 16698387 [TBL] [Abstract][Full Text] [Related]
67. H-ras mutation detection in bladder cancer by COLD-PCR analysis and direct sequencing. Wang AX; Chang JW; Li CY; Liu K; Lin YL Urol Int; 2012; 88(3):350-7. PubMed ID: 22433386 [TBL] [Abstract][Full Text] [Related]
68. Detection of H-ras gene point mutations in transitional cell carcinoma of human urinary bladder using polymerase chain reaction. Saito S Keio J Med; 1992 Jun; 41(2):80-6. PubMed ID: 1619852 [TBL] [Abstract][Full Text] [Related]
69. Alteration of the p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado. Enomoto T; Fujita M; Inoue M; Nomura T; Shroyer KR Am J Clin Pathol; 1995 Feb; 103(2):224-30. PubMed ID: 7856567 [TBL] [Abstract][Full Text] [Related]
70. [Detection of ras gene mutation in various stages of gastric cancer by PCR/RFLP SSCP and DNA sequencing]. Hao Y; Zhang J; Lu Y Zhonghua Nei Ke Za Zhi; 1997 Sep; 36(9):595-8. PubMed ID: 10436968 [TBL] [Abstract][Full Text] [Related]
71. Platelet-derived growth factor stimulation of GTPase-activating protein tyrosine phosphorylation in control and c-H-ras-expressing NIH 3T3 cells correlates with p21ras activation. Molloy CJ; Fleming TP; Bottaro DP; Cuadrado A; Aaronson SA Mol Cell Biol; 1992 Sep; 12(9):3903-9. PubMed ID: 1508192 [TBL] [Abstract][Full Text] [Related]
72. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Andrew AS; Nelson HH; Kelsey KT; Moore JH; Meng AC; Casella DP; Tosteson TD; Schned AR; Karagas MR Carcinogenesis; 2006 May; 27(5):1030-7. PubMed ID: 16311243 [TBL] [Abstract][Full Text] [Related]
73. [Detection and clinical pathological significance of the expression of P21, P185, p53 proteins and mutation of ras, p53 genes in transitional cell carcinoma of the bladder]. Yu D; Liu F; Liang Z Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):202-5. PubMed ID: 9275651 [TBL] [Abstract][Full Text] [Related]
74. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1. Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813 [TBL] [Abstract][Full Text] [Related]
75. Screening of human bladder tumors and urine sediments for the presence of H-ras mutations. Levesque P; Ramchurren N; Saini K; Joyce A; Libertino J; Summerhayes IC Int J Cancer; 1993 Nov; 55(5):785-90. PubMed ID: 7902340 [TBL] [Abstract][Full Text] [Related]
76. The role of Ras superfamily proteins in bladder cancer progression. Oxford G; Theodorescu D J Urol; 2003 Nov; 170(5):1987-93. PubMed ID: 14532839 [TBL] [Abstract][Full Text] [Related]
77. Association of p53 codon 248 (exon7) with urinary bladder cancer risk in the North Indian population. Jaiswal PK; Goel A; Mittal RD Biosci Trends; 2011; 5(5):205-10. PubMed ID: 22101376 [TBL] [Abstract][Full Text] [Related]
79. T-cell immunity to oncogenic proteins including mutated ras and chimeric bcr-abl. Cheever MA; Chen W; Disis ML; Takahashi M; Peace DJ Ann N Y Acad Sci; 1993 Aug; 690():101-12. PubMed ID: 8103658 [TBL] [Abstract][Full Text] [Related]
80. p53 codon 72 polymorphism and its association with bladder cancer. Soulitzis N; Sourvinos G; Dokianakis DN; Spandidos DA Cancer Lett; 2002 May; 179(2):175-83. PubMed ID: 11888672 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]